Efficacy and Safety of a Fixed Combination Extrafine Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide (BDP/FF/GB) pMDI Treatment Compared to Fixed Combination BDP/FF in Patients with Uncontrolled Asthma on Medium Dose ICS/LABA: The TRIMARAN Study

Fixed Combination ◽

Efficacy And Safety ◽

Uncontrolled Asthma ◽

Glycopyrronium Bromide ◽

Formoterol Fumarate ◽

Medium Dose

Effect of High ICS Dose Fixed Combination Extra Fine Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide (BDP/FF/GB) on Lung Function in Asthmatics with Persistent Airflow Limitation (PAL): A Post-Hoc Analysis of the TRIGGER Study

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3005 ◽

2020 ◽

Author(s):

D. Singh ◽

G.W. Cononica ◽

J.C. Virchow ◽

M. Kots ◽

F. Zuccaro ◽

...

Keyword(s):

Lung Function ◽

Fixed Combination ◽

Airflow Limitation ◽

Glycopyrronium Bromide ◽

Post Hoc Analysis ◽

Post Hoc ◽

Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s146822 ◽

2017 ◽

Vol Volume 12 ◽

pp. 2917-2928 ◽

Cited By ~ 16

Author(s):

Dave Singh ◽

Massimo Corradi ◽

Monica Spinola ◽

Alberto Papi ◽

Omar Usmani ◽

...

Keyword(s):

Triple Therapy ◽

Fixed Combination ◽

Glycopyrronium Bromide ◽

New Evidence ◽

Effect of Medium ICS Dose Fixed Combination Extra Fine Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide (BDP/FF/GB) pMDI on Lung Function in Asthmatics with Persistent Airflow Limitation (PAL): A Post-Hoc Analysis of the Trimaran Study

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3009 ◽

2020 ◽

Author(s):

J.C. Virchow ◽

G.W. Canonica ◽

D. Singh ◽

M. Kots ◽

S. Corre ◽

...

Keyword(s):

Lung Function ◽

Fixed Combination ◽

Airflow Limitation ◽

Glycopyrronium Bromide ◽

Post Hoc Analysis ◽

Post Hoc ◽

Pharmacokinetics of the Extrafine Fixed-Dose Combination of Beclomethasone Dipropionate, Formoterol Fumarate, Glycopyrronium Bromide Delivered Via a Pressurized-Metered Dose Inhaler (pMDI) in Chinese Subjects

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4527 ◽

2019 ◽

Author(s):

G. Georges ◽

Z. Luo ◽

G. Ciurlia ◽

P. Guller ◽

L. Girardello ◽

...

Keyword(s):

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Glycopyrronium Bromide ◽

Metered Dose ◽

Dose Combination ◽

Chinese Subjects ◽

Comparison of a dry powder inhaler (DPI) to a pressurized metered-dose inhaler (pMDI) formulation of extra fine beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide (BDP/FF/GB) in patients with COPD: The TRI-D study

10.1183/13993003.congress-2020.3246 ◽

2020 ◽

Author(s):

Kai Michael Beeh ◽

Piotr Kuna ◽

Isabelle Viaud ◽

Alessandro Guasconi ◽

Massimo Corradi ◽

...

Keyword(s):

Dry Powder Inhaler ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Dry Powder ◽

Glycopyrronium Bromide ◽

Metered Dose ◽

Pressurized Metered Dose Inhaler ◽

Normalization of Airflow Obstruction with Extra Fine Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide (BDP/FF/GB) pMDI: A Post-Hoc Analysis of the TRIMARAN and TRIGGER Studies

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1437 ◽

2021 ◽

Author(s):

J.C. Virchow ◽

D. Singh ◽

W.G. Canonica ◽

A. Vele ◽

G. Georges ◽

...

Keyword(s):

Airflow Obstruction ◽

Glycopyrronium Bromide ◽

Post Hoc Analysis ◽

Post Hoc ◽

LATE-BREAKING ABSTRACT: TRINITY: A phase III study to compare the efficacy and safety of an extrafine triple combination of beclometasone dipropionate (BDP), formoterol fumarate (FF), and glycopyrronium bromide (GB) pMDI (CHF5993) with tiotropium (Tio) and a free triple combination of BDP/FF (Foster®) + Tio in COPD patients

10.1183/13993003.congress-2016.oa1972 ◽

2016 ◽

Author(s):

Jorgen Vestbo ◽

Massimo Corradi ◽

Isabella Montagna ◽

Géraldine Cohuet ◽

Catherine Francisco ◽

...

Keyword(s):

Phase Iii ◽

Efficacy And Safety ◽

Triple Combination ◽

Glycopyrronium Bromide ◽

Copd Patients ◽

Phase Iii Study ◽

LATE-BREAKING ABSTRACT: TRILOGY: a phase III study to evaluate the efficacy and safety of an extrafine triple combination of beclometasone dipropionate (BDP), formoterol fumarate (FF), and glycopyrronium bromide (GB) pMDI (CHF5993) in COPD patients

10.1183/13993003.congress-2016.pa995 ◽

2016 ◽

Author(s):

Dave Singh ◽

Alberto Papi ◽

Massimo Corradi ◽

Isabella Montagna ◽

Catherine Francisco ◽

...

Keyword(s):

Phase Iii ◽

Efficacy And Safety ◽

Triple Combination ◽

Glycopyrronium Bromide ◽

Copd Patients ◽

Phase Iii Study ◽

Extrafine glycopyrronium bromide (GB) in addition to extrafine beclomethasone dipropionate/formoterol fumarate (BDP/FF) in uncontrolled asthmatic patients

10.1183/13993003.congress-2018.pa607 ◽

2018 ◽

Author(s):

Dave Singh ◽

George Georges ◽

Mario Scuri ◽

Ilaria Valente ◽

Alessandro Guasconi ◽

...

Keyword(s):

Glycopyrronium Bromide ◽

Asthmatic Patients ◽

Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide as a combination therapy for chronic obstructive pulmonary disease

Expert Review of Respiratory Medicine ◽

10.1080/17476348.2019.1548937 ◽

2018 ◽

Vol 13 (1) ◽

pp. 5-11

Author(s):

Maciej Kupczyk ◽

Piotr Kuna

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Combination Therapy ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Glycopyrronium Bromide ◽